None listed
Conditions
Interventions
Group C:Mivacurium
Conrol group:Cis atracurium
Sponsors
The First Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-60 years old, American Society of Anesthesiologists physical status I-II, body mass index (BMI) 18.5-23.9; 2. Patients with good general condition underwent endotracheal intubation and general anesthesia day surgery; 3. Ethical, patients were willing to participate in the study and signed informed consent.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Patients with known allergy to mivacurium; 2. Complicated with serious organic diseases such as brain, heart, liver, and kidney; 3. Asthma patients; 4. Myasthenia gravis and myasthenic syndrome have abnormal effects on muscle relaxants; Drugs affecting neuromuscular conduction function were used before the operation; 5. Pregnancy or lactation; 6. Patients with acid-base imbalance and electrolyte disorder. The withdrawal criteria were as follows: 1. Admission to ICU after operation; 2. Severe bleeding (bleeding volume > 30%) and serious cardiovascular events (malignant arrhythmia, acute myocardial ischemia, etc.) occurred during the operation; 3. Patients withdrew by themselves; 4. Failure to complete the trial according to the procedure for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset and clinical action time of muscle relaxants; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative patient consciousness was evaluated; | — |
Countries
China
Contacts
Public ContactXie Yubo
The First Affiliated Hospital of Guangxi Medical University
Outcome results
None listed